255 related articles for article (PubMed ID: 3955554)
1. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
2. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
Magdon E; Schröder E
Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Rockwell S
Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
[TBL] [Abstract][Full Text] [Related]
6. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
7. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
Rockwell S; Kelley M
Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
[TBL] [Abstract][Full Text] [Related]
8. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
[TBL] [Abstract][Full Text] [Related]
9. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
Rockwell S; Schulz RJ
Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
[TBL] [Abstract][Full Text] [Related]
10. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
Thomas CD; Chavaudra N; Martin L; Guichard M
Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
[TBL] [Abstract][Full Text] [Related]
11. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
Keyes SR; Rockwell S; Sartorelli AC
Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
Brown JM; Yu NY; Cory MJ; Bicknell RB; Taylor DL
Br J Cancer Suppl; 1978 Jun; 3():206-11. PubMed ID: 277229
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
Taylor YC; Brown JM
Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizers: rationale and potential.
Brown JM
Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
[TBL] [Abstract][Full Text] [Related]
15. Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.
Horsman MR; Chaplin DJ; Brown JM
Radiat Res; 1989 Apr; 118(1):139-50. PubMed ID: 2523079
[TBL] [Abstract][Full Text] [Related]
16. Effects of dimethyl sulfoxide and hypoxic cell radiosensitizers on the radiation response of the KHT murine tumor in vivo.
Rauth AM; Paciga JE
Radiat Res; 1977 Feb; 69(2):248-57. PubMed ID: 841003
[No Abstract] [Full Text] [Related]
17. Testing of hypoxic cell radiosensitizers in vivo.
Rauth AM; Chin J; Marchow L; Paciga J
Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
[TBL] [Abstract][Full Text] [Related]
18. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
[TBL] [Abstract][Full Text] [Related]
19. [The radiation sensitizing activity of metronidazole and iso-metronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole)].
Proskurjakov SJ; Smoryzanova OA; Rjabcenko NI; Dedenkov AN
Radiobiol Radiother (Berl); 1990; 31(6):531-6. PubMed ID: 2101458
[TBL] [Abstract][Full Text] [Related]
20. [Radiosensitizing and toxic effect of metronidazole and its ortho-isomer 1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole on Escherichia coli B/r cells].
Riabchenko NI; Petrova KM; Proskuriakov SIa
Radiobiologiia; 1985; 25(6):744-7. PubMed ID: 3909211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
